Fair Prescription Pricing Act of 2026
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsor
- 1
- Latest action
- Aug 20, 2026
What it does
The Fair Prescription Pricing Act of 2026 would limit cost sharing for prescription drugs—such as deductibles, coinsurance, and copayments—to no more than the nationwide average consumer purchase price for each drug, as determined by a federal survey. It applies to group health plans and health insurance issuers offering group or individual coverage under the Public Health Service Act, ERISA, and the Internal Revenue Code, and requires pharmacy benefit managers to comply with these limits. The rule takes effect for plan years beginning on or after the date of enactment and uses data from the Social Security Act’s drug pricing survey to calculate the average price.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.